Draft Indian pricing policy may sour investment sentiment, experts warn
This article was originally published in Scrip
Executive Summary
India's new draft national pharmaceutical pricing policy could make the domestic industry less attractive for the investing community, in turn eroding opportunities for local firms, according to a clutch of industry experts.